(Q39421938)

11 September 2017

title

Neuromelanin enhances the toxicity of α-synuclein in SK-N-SH cells (English)

1 reference

11 September 2017

1 reference

Jie Li

1

1 reference

11 September 2017

Junfeng Yang

2

1 reference

11 September 2017

Peng Zhao

3

1 reference

11 September 2017

Shen Li

4

1 reference

11 September 2017

Renyun Zhang

5

1 reference

11 September 2017

Xiaobin Zhang

6

1 reference

11 September 2017

Dan Liu

7

1 reference

11 September 2017

Benshu Zhang

8

1 reference

11 September 2017

language of work or name

1 reference

27 December 2011

1 reference

Journal of Neural Transmission

11 September 2017

published in

1 reference

11 September 2017

volume

119

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

685-691

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-011-0753-z

11 September 2017

exact match

0 references

cites work

Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Animal models of PD: pieces of the same puzzle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Iron-binding characteristics of neuromelanin of the human substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Modulation of alpha-synuclein aggregation by dopamine: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Dopamine differentially induces aggregation of A53T mutant and wild type alpha-synuclein: insights into the protein chemistry of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0753-Z

Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins

21 January 2018

1 reference

12 December 2020

Pigments in the red nucleus and substantia nigra in man and in representative old and new world monkeys

1 reference

12 December 2020

The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour

1 reference

12 December 2020

Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.

1 reference

12 December 2020

10.1007/S00702-011-0753-Z

Identifiers

DOI

1 reference

11 September 2017

1 reference